Report cover image

Bacteriophage Therapy Market

Publisher Coherent Market Insights
Published Sep 11, 2023
Length 180 Pages
SKU # CMI18237974

Description

Bacteriophage Therapy Market, By Targeted Bacteria (Escherichia coli, Staphylococcus aureus, Streptococcus, Pseudomonas aeruginosa, Salmonella, and Others), By Disease Indication (Urinary Tract Infections, Chronic Otitis, Dental Extraction, Chronic Ulcerative Colitis, Bone Infection, Wound and Skin Infections, Cystic Fibrosis, and Other, By Route of Administration (Oral, Topical, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are one of the most common biological entities that can effectively fight and destroy multi-drug-resistant bacteria. When all antibiotics fail to work against an infection, the phages are able to kill the bacteria causing the infection, thus helping medical professionals save life. Bacteriophages are being considered as a new alternative to antibiotics. In this therapy, the viruses are used to inject their genetic material into bacteria and use their host machinery to multiply themselves. This phage therapy is used to treat or prevent bacterial infections in patients’ bodies. Bacteriophage therapy also plays a significant role in the research fields of molecular biology and biotechnology. These factors enhance the potential scope for drug discovery.

Market Dynamics

The increasing organic growth strategies, such as product approval by regulatory authorities to expand key players market portfolio, are expected to drive market growth over the forecast period. For instance, in September 2021, Adaptive Phage Therapeutics, Inc. (APT), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, announced that the Department of Defense (DoD), an executive branch department of the federal government of the U.S., had awarded the company an additional US$8 million for the continued development of bacteriophage therapies (APT’s phage bankTM) for the treatment of infectious diseases. Adaptive Phage Therapeutics, Inc. said that it is thrilled APT’s phage bank platform helps to treat drug-resistant infections across multiple indications that create potentially lifesaving therapies for the nation’s service members.

Key features of the study:
  • This report provides an in-depth analysis of the global bacteriophage therapy market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global bacteriophage therapy market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Armata Pharmaceuticals, Inc., Eliava Biopreparations Ltd., Pherecydes Pharma, Intralytix, Inc., Phagelux, Inc., Nextbiotics, InnoPhage, Ltd, Locus Biosciences, Inc., TechnoPhage, Eligo Bioscience SA, Phagomed Biopharma GmbH., PhagePro, Inc., Adaptive Phage Therapeutics, Enbiotix, Inc., Intodeworld, Inc., BiomX Ltd., Phi Therapeutics, Fixed-phage Ltd., Micreos BV, ContraFect Corporation, OPTIPHARM Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global Bacteriophage Therapy Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bacteriophage therapy market.
Detailed Segmentation:
  • Global Bacteriophage Therapy Market, By Targeted Bacteria:
  • Escherichia coli
  • Staphylococcus aureus
  • Streptococcus
  • Pseudomonas aeruginosa
  • Salmonella
  • Others
  • Global Bacteriophage Therapy Market, By Disease Indication:
  • Urinary Tract Infections
  • Chronic Otitis
  • Dental Extraction
  • Chronic Ulcerative Colitis
  • Bone Infection
  • Wound and Skin Infections
  • Cystic Fibrosis
  • Others
  • Global Bacteriophage Therapy Market, By Route of Administration:
  • Oral
  • Topical
  • Parenteral
  • Global Bacteriophage Therapy Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Bacteriophage Therapy Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • Company Profiles
  • Armata Pharmaceuticals, Inc.
  • Eliava Biopreparations Ltd.
  • Pherecydes Pharma
  • Intralytix, Inc.
  • Phagelux, Inc.
  • Nextbiotics
  • InnoPhage, Ltd
  • Locus Biosciences, Inc.
  • TechnoPhage
  • Eligo Bioscience SA
  • Phagomed Biopharma GmbH.
  • PhagePro, Inc.
  • Adaptive Phage Therapeutics
  • Enbiotix, Inc.
  • Intodeworld, Inc.
  • BiomX Ltd.
  • Phi Therapeutics
  • Fixed-phage Ltd.
  • Micreos BV
  • ContraFect Corporation
  • OPTIPHARM Co., Ltd.

Table of Contents

180 Pages
1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Targeted Bacteria
Market Snippet, By Disease Indication
Market Snippet, By Route of Administration
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
4. Global Bacteriophage Therapy Market, – COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Bacteriophage Therapy Market, By Targeted Bacteria, 2018 - 2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
Escherichia coli
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Staphylococcus aureus
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Staphylococcus aureus
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Streptococcus
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Pseudomonas aeruginosa
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Salmonella
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
6. Global Bacteriophage Therapy Market, By Disease Indication, 2018 – 2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
Urinary Tract Infections
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Chronic Otitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Dental Extraction
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Chronic Ulcerative Colitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Bone Infection
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Wound and Skin Infections
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Cystic Fibrosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
7. Global Bacteriophage Therapy Market, By Route of Administration, 2018 – 2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Topical
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Parenteral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
8. Global Bacteriophage Therapy Market, By Distribution Channel, 2018 – 2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
9. Global Bacteriophage Therapy Market, By Region, 2018 – 2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
North America
Introduction
Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 –2030, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 –2030, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 –2030, (US$ Mn)
Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018–2030, (US$ Mn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Mn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 –2030, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 –2030, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 –2030, (US$ Mn)
Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018–2030, (US$ Mn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 –2030, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 –2030, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 –2030, (US$ Mn)
Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018–2030, (US$ Mn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 –2030, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 –2030, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 –2030, (US$ Mn)
Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018–2030, (US$ Mn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 –2030, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 –2030, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 –2030, (US$ Mn)
Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018–2030, (US$ Mn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 –2030, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 –2030, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 –2030, (US$ Mn)
Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018–2030, (US$ Mn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 –2030, (US$ Mn)
North Africa
Central Africa
South Africa
10. Competitive Landscape
Company Profiles
Armata Pharmaceuticals, Inc. *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Eliava Biopreparations Ltd
Pherecydes Pharma
Intralytix, Inc.
Phagelux, Inc.
Intralytix, Inc.
Nextbiotics
InnoPhage, Ltd
Locus Biosciences, Inc.
TechnoPhage
Eligo Bioscience SA
Phagomed Biopharma GmbH
PhagePro, Inc.
Adaptive Phage Therapeutics
Enbiotix, Inc
Intodeworld, Inc.
BiomX Ltd.
Phi Therapeutics
Fixed-phage Ltd
Micreos BV
ContraFect Corporation
OPTIPHARM Co., Ltd.
11. Section
References
Research Methodology
About us and Sales Contact
*Browse 44 market data tables and 45 figures on “Global Bacteriophage Therapy Market,” – Global forecast to 2030

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us